1 Jul 2021 17:05
EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO
EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
SLN.L Share News (SLN)
SLN Share
Price
SLN Share
News
SLN Share
Chat
SLN Share
Trades
SLN
Live RNS
SLN Share
Charts
SLN Broker
Ratings
SLN Directors
Deals
SLN Financial
Diary
SLN
Fundamentals
SLN Short
Positions
SLN
Media
SLN.L Information
- There is currently no data for SLN
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.8 Jun 2021 16:03
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
Read more7 Jun 2021 08:51
Silence Therapeutics to present positive data from 'SLN124'
(Sharecast News) - Silence Therapeutics announced on Monday that it would present data showing the potential for 'SLN124' to address a range of hematological diseases by targeting the liver-expressed gene TMPRSS6.
Read more2 Jun 2021 16:02
EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus
EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus
Read more25 May 2021 19:40
TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
Read more25 May 2021 12:35
Silence Therapeutics receives remaining $40m from AstraZeneca partnership
(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA collaboration announced in March 2020.
Read more19 May 2021 19:33
TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment
TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment
Read more19 May 2021 10:20
Silence Therapeutics reveals positive data from SLN124 study
(Sharecast News) - Silence Therapeutics announced positive topline data from the 'GEMINI' phase 1 study of its wholly-owned product candidate 'SLN124' in healthy volunteers on Wednesday.
Read more29 Apr 2021 14:34
TRADING UPDATES: STV looks to summer's football; In The Style sales up
TRADING UPDATES: STV looks to summer's football; In The Style sales up
Read more29 Apr 2021 09:48
Silence Therapeutics doses first patient in 'GEMINI II' study
(Sharecast News) - Silence Therapeutics announced on Thursday that the first patient has been dosed in the 'GEMINI II' phase 1 clinical study of its wholly-owned lead product candidate, SLN124, for the treatment of 'iron-loading' anemias, thalassemia and myelodysplastic syndrome (MDS).
Read more28 Apr 2021 19:20
IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone
IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone
Read more28 Apr 2021 13:33
Silence Therapeutics gets $2m milestone payment from Mallinckrodt
(Sharecast News) - Silence Therapeutics has achieved another research milestone as part of its ongoing RNAi collaboration with Mallinckrodt for complement-mediated diseases, it announced on Wednesday, triggering a further $2m payment.
Read more19 Apr 2021 14:58
DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth
DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth
Read more30 Mar 2021 20:33
TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing
TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing
Read more23 Mar 2021 16:07
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more